Women's Health News

RSS

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Actamax Surgical Materials LLC, a DSM-DuPont Joint Venture focusing on the development and commercialization of resorbable, biocompatible surgical medical devices, today announced positive safety and efficacy results from the first clinical evaluation of its novel adhesion barrier device.

11 Nov 2014

Survey: Majority of U.S. adult women do not believe that they are up to date on vaccinations

A national survey from Rite Aid and National Foundation for Infectious Diseases reveals that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases.

11 Nov 2014

Internet based screening mammography training: an interview with Dr. Holzhauer

About half of Radiologists in the USA who participate in breast imaging are estimated to read less than 2,000 screening mammograms per year. This is a suboptimal number, given that only 3-5 cancers in average are seen among 1,000 screening mammograms.

10 Nov 2014

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

Eribulin (trade name: Halaven) is approved for women with locally advanced or metastatic breast cancer in whom the disease has progressed despite prior drug therapy. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in these patient groups.

7 Nov 2014

Single mutation in beta-catenin gene can lead to infertility

Scientists from the RIKEN BioResource Center in Tsukuba, Japan, have discovered that a single mutation in the beta-catenin gene, which codes a protein known to be deeply involved in a number of developmental and homeostatic processes, can lead to infertility not through a disruption of the production of egg or sperm cells, but rather by leading to abnormalities in the morphology of the sexual organs, making natural reproduction impossible.

7 Nov 2014

Olaparib shows promise for advanced cancers associated with BRCA1 and BRCA2 mutations

Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.

7 Nov 2014

Journal highlights health outcomes of women veterans

In honor of Veterans Day, the peer-reviewed journal Women's Health Issues (WHI) today released a new Special Collection on women veterans' health, with a focus on mental health. The special collection also highlights recent studies addressing healthcare services, reproductive health and cardiovascular health of women veterans.

7 Nov 2014

Osteoporosis drugs may also benefit patients with tumours outside the skeleton

Australian researchers have shown why calcium-binding drugs commonly used to treat people with osteoporosis, or with late-stage cancers that have spread to bone, may also benefit patients with tumours outside the skeleton, including breast cancer.

6 Nov 2014

Study sheds light on DCIS recurrence

Work by University of Manchester scientists has explored what allows some cases of Ductal Carcinoma in Situ (DCIS), a non-invasive form of breast cancer, to resist treatment and come back, as well as identifying a potential new target to improve the effectiveness of radiotherapy.

6 Nov 2014

Joslin researcher identifies molecular pathway that causes neural tube defects in diabetic pregnancies

Mary R. Loeken, Ph.D., Investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and Associate Professor of Medicine at Harvard Medical School, has discovered a molecular pathway responsible for neural tube defects in diabetic pregnancies. Her latest research findings in this pathway were published in the October issue of Diabetes.

6 Nov 2014

Study: Hot flashes are not adequately managed in patients treated for breast cancer

Hot flushes are one of the most distressing conditions faced by women who have been treated for breast cancer, but they are not being adequately addressed by healthcare professionals and some women consider giving up their post cancer medication to try and stop them, a new study has shown.

6 Nov 2014

Eight million US women skip cervical cancer screening in the past five years

Despite evidence that cervical cancer screening saves lives, about eight million women ages 21 to 65 years have not been screened for cervical cancer in the past five years, according to a new Vital Signs report from the Centers for Disease Control and Prevention. More than half of new cervical cancer cases occur among women who have never or rarely been screened.

6 Nov 2014

Study measures effects of high-fat maternal diet on the cognitive functioning of offspring

New research suggests that a high-fat maternal diet during pregnancy and while breastfeeding could have significant and lasting detrimental effects on the brain function and behavior of children.

5 Nov 2014

Dietary supplement KoACT is superior to calcium, vitamin D for bone health, study reveals

A new study by a Florida State University researcher reveals that a new dietary supplement is superior to calcium and vitamin D when it comes to bone health.

5 Nov 2014

New studies offer hope for breast cancer survivors struggling with cancer-related pain, swelling

Two new studies from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania offer hope for breast cancer survivors struggling with cancer-related pain and swelling, and point to ways to enhance muscular strength and body image.

5 Nov 2014

Clinical study data of Advaxis' Lm-LLO immunotherapies to be presented at SITC Annual Meeting

Advaxis, Inc., a cancer immunotherapy company, today announced the abstracts of three preclinical and clinical studies highlighting the survival outcomes and anti-tumor effects of its proprietary Lm-LLO cancer immunotherapy technology at the Society for Immunotherapy of Cancer (SITC) 29th Annual Meeting, November 6-9, 2014 at the Gaylord National Hotel and Convention Center in National Harbor, Maryland.

5 Nov 2014

Study reveals impact of meditation, support groups at cellular level in breast cancer survivors

For the first time, researchers have shown that practising mindfulness meditation or being involved in a support group has a positive physical impact at the cellular level in breast cancer survivors.

4 Nov 2014

People with lactose intolerance at lower risk of suffering from certain cancers

People with lactose intolerance are at lower risk of suffering from lung, breast and ovarian cancers, according to a new study by researchers at Lund University and Region Skåne in Sweden.

4 Nov 2014

Pregnant women with bipolar disorder at greater risk of delivering premature babies

Women who have been previously hospitalized for bipolar disorder are nearly twice as likely to have premature babies compared to women without a history of mental illness, according to a new study by researchers at Women's College Hospital and the Institute for Clinical Evaluative Sciences.

4 Nov 2014

Seno Imagio breast imaging system and associated predictive model can help eliminate breast biopsies

Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced that the use of the Seno Imagio breast imaging system and the associated predictive model appear to have the potential to significantly improve the physicians’ ability to accurately rule out breast cancer compared to traditional ultrasound alone.

4 Nov 2014

Women's Health News

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Survey: Majority of U.S. adult women do not believe that they are up to date on vaccinations

Internet based screening mammography training: an interview with Dr. Holzhauer

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

Single mutation in beta-catenin gene can lead to infertility

Olaparib shows promise for advanced cancers associated with BRCA1 and BRCA2 mutations

Journal highlights health outcomes of women veterans

Osteoporosis drugs may also benefit patients with tumours outside the skeleton

Study sheds light on DCIS recurrence

Joslin researcher identifies molecular pathway that causes neural tube defects in diabetic pregnancies

Study: Hot flashes are not adequately managed in patients treated for breast cancer

Eight million US women skip cervical cancer screening in the past five years

Study measures effects of high-fat maternal diet on the cognitive functioning of offspring

Dietary supplement KoACT is superior to calcium, vitamin D for bone health, study reveals

New studies offer hope for breast cancer survivors struggling with cancer-related pain, swelling

Clinical study data of Advaxis' Lm-LLO immunotherapies to be presented at SITC Annual Meeting

Study reveals impact of meditation, support groups at cellular level in breast cancer survivors

People with lactose intolerance at lower risk of suffering from certain cancers

Pregnant women with bipolar disorder at greater risk of delivering premature babies

Seno Imagio breast imaging system and associated predictive model can help eliminate breast biopsies

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News